|
CEP110 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.766430E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.913590E-01 |
| Normal-vs-Stage2 |
4.198800E-04 |
| Normal-vs-Stage3 |
8.201800E-03 |
| Normal-vs-Stage4 |
7.977200E-03 |
| Stage1-vs-Stage2 |
9.037900E-04 |
| Stage1-vs-Stage3 |
4.407900E-02 |
| Stage1-vs-Stage4 |
2.239700E-02 |
| Stage2-vs-Stage3 |
6.177700E-02 |
| Stage2-vs-Stage4 |
1.977580E-01 |
| Stage3-vs-Stage4 |
6.349400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.682100E-02 |
| Normal-vs-AfricanAmerican |
6.046000E-02 |
| Normal-vs-Asian |
4.666000E-01 |
| Caucasian-vs-AfricanAmerican |
3.570800E-01 |
| Caucasian-vs-Asian |
3.569400E-01 |
| AfricanAmerican-vs-Asian |
1.692410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.394100E-02 |
| Normal-vs-Female |
1.637970E-02 |
| Male-vs-Female |
6.909600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.440000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.454180E-02 |
| Normal-vs-Age(61-80Yrs) |
2.570400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.833700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.036200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.351940E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.280500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.726300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.528780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.973600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.163500E-02 |
| Classical-VS-Follicular |
9.86780002154575E-09 |
| Classical-VS-Other |
5.595000E-01 |
| Classical-VS-Normal |
2.958800E-01 |
| Tall-VS-Follicular |
8.018200E-02 |
| Tall-VS-Other |
7.639600E-01 |
| Tall-VS-Normal |
4.954500E-02 |
| Follicular-VS-Other |
2.206200E-01 |
| Follicular-VS-Normal |
1.78958000000007E-05 |
| Other-VS-Normal |
4.055400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.501550E-03 |
| Normal-vs-N1 |
1.560490E-02 |
| N0-vs-N1 |
9.430800E-01 |
|
|
